Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai‐Dong Zhu, Jian Wang, Zhi‐Cheng Jin et al.|Signal Transduction and Targeted Therapy|2023Cited by 295
RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinomaWei Zhou, Wenxiang Wei, Qi Wang et al.|Oncotarget|2017Cited by 25
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapyDefa Huang, Tianyu Zhong, Fangfang Xie et al.|Scientific Reports|2024Cited by 0